Translational Global Infectious Diseases Research Center
转化全球传染病研究中心
基本信息
- 批准号:10706797
- 负责人:
- 金额:$ 228.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-15 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesApplications GrantsAreaAwardCOVID-19 pandemicCenters of Research ExcellenceClinicalCollaborationsCommunicable DiseasesComplementComputer ModelsCore FacilityData ScientistDedicationsDevelopmentDisciplineEducationEvaluationFacultyFaculty RecruitmentFosteringFundingGoalsGrantGrowthHumanIndividualInfectious Diseases ResearchInstitutionLanguageLeadershipLogisticsMathematicsMentorsMissionModelingMorbidity - disease ratePhasePhysiciansPilot ProjectsPopulationPopulation ResearchPositioning AttributePreventionProcessProgram DevelopmentReportingResearchResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingResource-limited settingRoleScholars ProgramScienceScientistServicesStructureTraining ProgramsTraining and EducationUniversitiesUpdateVermontacademic programbiobankcareercareer developmentdata managementdesignexperiencefaculty supportglobal healthimprovedinterestmeetingsmembermortalitymultidisciplinarynext generationnovelpredictive modelingpreventprogramsrecruitresearch and developmentsenior facultysuccesstraining opportunityvisiting scholar
项目摘要
PROJECT SUMMARY: Overall
As demonstrated by the COVID-19 pandemic, infectious diseases are dynamic, constantly evolving threats that
cause significant morbidity and mortality in all populations worldwide. The University of Vermont’s Translational
Global Infectious Diseases Research (TGIR) Center of Biomedical Research Excellence (COBRE) began in
2018 under a Phase 1 award with aims to support and develop the research careers of the next generation of
scientists and to build institutional strength in global infectious disease research. The TGIR COBRE’s
overarching scientific goal is to perform impactful research to prevent and control infectious diseases of global
significance, particularly in low-resource regions of the world. A unique feature of the TGIR COBRE is its
commitment to bridging the culture gap between biomedical and quantitative data scientists. Phase 1 funding
successfully supported seven research project leaders (RPLs), recruited four new junior faculty, and began a
pilot award program that funded nine additional research projects. The Administrative Core offered
comprehensive scientific, administrative, and career-development support, and new educational and academic
programs, including Mentoring and Visiting Scholar Programs. The two research cores - the Human and
Population Research (HPR) Core and the Mathematical and Computational Predictive Modeling (MCP) Core –
provided prioritized services directly to RPLs, pilot project awardees, and junior faculty recruits in addition to
educational and training opportunities.
Phase 2 of the TGIR COBRE will build and consolidate this institutional growth and critical mass of faculty,
including retention opportunities for ‘graduated’ RPLs. With a primary focus on developing junior faculty, and
with the help of senior mentors and an improved mentoring plan, the TGIR COBRE will initially support the
careers and research of four RPLs as well as new pilot award faculty. Three externally recruited faculty will
complement existing areas of research strength. In addition, the TGIR COBRE will focus on RPL pipeline
faculty and on broadening collaborations across campus and with other IDeA state programs. With institutional
support, new initiatives in Phase 2 will position the TGIR COBRE for long term success. These initiatives
include plans for multi-disciplinary grant proposals and provision of formal grant writer support. Financial and
logistic support will also be provided for national scientific meetings to be held at UVM in order to broaden
networking, visibility, and collaborative opportunities. A bioinformatician has been added to the MCP Core,
expanded data management and biorepository services have been added to the HPR Core, and the
Administrative Core now has enhanced focus on career development for physician-scientists. Evaluation of
TGIR COBRE progress will be a continuous process led by the Leadership Team with the support of a
dedicated Advisory Committee. We anticipate the TGIR COBRE becoming a sustainable academic research
hub in global infectious diseases.
项目摘要:总体
正如共同-19大流行所证明的那样,传染病是动态的,不断发展的威胁,
在全球所有人口中引起明显的发病率和死亡率。佛蒙特大学的翻译
全球传染病研究(TGIR)生物医学研究卓越中心(COBRE)始于
2018年第1阶段奖项,旨在支持和发展下一代的研究生涯
科学家并在全球传染病研究中建立机构力量。 Tgir cobre的
总体科学目标是进行有影响力的研究,以预防和控制全球的传染病
意义,尤其是在世界的低资源地区。 Tgir Cobre的一个独特功能是
致力于弥合生物医学和定量数据科学家之间的培养差距。第一阶段基础
成功支持七位研究项目领导者(RPLS),招募了四个新的初级教师,并开始
试点奖计划资助了九个其他研究项目。行政核心提供
全面的科学,行政和职业发展支持以及新的教育和学术
计划,包括指导和访问学者计划。这两个研究核心 - 人类和
人口研究(HPR)核心以及数学和计算预测建模(MCP)核心 -
直接向RPLS,试点项目获奖者和初级教师报告提供了优先的服务。
教育和培训机会。
TGIR COBRE的第2阶段将建立和巩固这一机构增长和教师的临界质量,
包括“毕业” RPL的保留机会。主要专注于发展初级教师,并
在高级导师和改进的心理计划的帮助下,Tgir Cobre最初将支持
四个RPL以及新的飞行员奖的职业和研究。三个外部招募的教师将
补充现有的研究力量领域。此外,TGIR COBRE将重点放在RPL管道上
教师以及在校园和其他思想国家计划中扩大合作。与机构
支持,第2阶段的新计划将使TGIR COBRE保持长期成功。这些举措
包括多学科赠款建议的计划,并提供正式的赠款作者支持。财务和
还将为在UVM举行的国家科学会议提供后勤支持,以扩大
网络,可见性和协作机会。一位生物信息学家已被添加到MCP核心
扩展的数据管理和生物座位服务已添加到HPR核心,
现在,行政核心已增强了对身体科学家职业发展的关注。评估
TGIR COBRE进步将是由领导团队领导的连续过程
专门的咨询委员会。我们预计TGIR COBRE成为一项可持续的学术研究
全球传染病中的枢纽。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Beth Diane Kirkpatrick其他文献
Beth Diane Kirkpatrick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Beth Diane Kirkpatrick', 18)}}的其他基金
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
对登革热流行人群中重组 DENV-2 病毒攻击的四价登革热减毒活疫苗 TetraVax-DV 的安全性和保护效果进行 II 期评估
- 批准号:
10219920 - 财政年份:2019
- 资助金额:
$ 228.75万 - 项目类别:
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
对登革热流行人群中重组 DENV-2 病毒攻击的四价登革热减毒活疫苗 TetraVax-DV 的安全性和保护效果进行 II 期评估
- 批准号:
10673589 - 财政年份:2019
- 资助金额:
$ 228.75万 - 项目类别:
Multi-Scale Modeling of SARS-CoV-2 Dissemination Dynamics
SARS-CoV-2 传播动力学的多尺度建模
- 批准号:
10402634 - 财政年份:2018
- 资助金额:
$ 228.75万 - 项目类别:
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
预防和控制全球传染病的转化研究(转化全球传染病研究中心,TGIR)。
- 批准号:
10021005 - 财政年份:2018
- 资助金额:
$ 228.75万 - 项目类别:
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
预防和控制全球传染病的转化研究(转化全球传染病研究中心,TGIR)。
- 批准号:
10853787 - 财政年份:2018
- 资助金额:
$ 228.75万 - 项目类别:
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
预防和控制全球传染病的转化研究(转化全球传染病研究中心,TGIR)。
- 批准号:
10256812 - 财政年份:2018
- 资助金额:
$ 228.75万 - 项目类别:
相似海外基金
Raise Awareness In Students Early (RAISE) Host and Microbe Program
早期提高学生意识 (RAISE) 宿主和微生物计划
- 批准号:
10628899 - 财政年份:2023
- 资助金额:
$ 228.75万 - 项目类别: